Multi-contrast Versus Multi-sequence Carotid MRI

Recruiting now

Conditions studied: Atherosclerosis

In brief

The objective of this study is to validate 2 multi-contrast sequences, namely the Multi-contrast ATherosclerosis Characterization (MATCH) and Bright-blood and black-blOOd phase SensiTive (BOOST) inversion recovery sequence for the quantification of atherosclerotic plaque components with conventional multi-sequence MRI and histology.

Key facts

Study ID

NCT04569006

Run by

Maastricht University Medical Center

People needed

40

Starts

2021-04-08

Expected to finish

2025-04-01

Last updated by the study team

2024-11-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• In order to be eligible to participate in this study, a subject must meet the following criteria:
• Patients with a carotid plaque ≥ 2 mm thick based on ultrasound or CTA
• Age 18 years or older (no maximum age)
• Informed consent by signing informed consent form regarding this study

You may not qualify if…

• A potential subject who meets any of the following criteria will be excluded from participation in this study:
• Patients with carotid plaque ≤ 2 mm in size based on ultrasound or CTA
• Standard contra-indications for MRI (electronic implants like pacemakers or other electronic implants, metallic eye fragments, vascular clips, claustrophobia, etc.)
• Severe co-morbidity, dementia or pregnancy

Where it is running

• Maastricht University Medical Center — Maastricht, Limburg, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.